"Designing Growth Strategies is in our DNA"

U.S. Plasma Fractionation Market Size, Share & COVID-19 Impact Analysis, By Product (Albumin, Immunoglobulin [Intravenous Immunoglobulin {IVIG}, Subcutaneous Immunoglobulin {SCIG}], Coagulation Factors [Factor IX, Factor VIII, Prothrombin Complex Concentrates, Fibrinogen Concentrates, and Others], Protease Inhibitors, and Others), By Application (Immunology & Neurology, Hematology, Critical Care, Pulmonology, and Others), By End-user (Hospitals & Clinics, Clinical Research Laboratories, and Others), and Country Forecast, 2023-2030

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI108476

 


To get information on various segments, share your queries with us

ATTRIBUTE

DETAILS

Study Period

2019-2030

Base Year

2022

Estimated Year

2023

Forecast Period

2023-2030

Historical Period

2019-2021

Growth Rate

CAGR of 7.5% from 2023 to 2030

Unit

Value (USD Billion)

Segmentation

By Product

  • Albumin
  • Immunoglobulin
    • Intravenous Immunoglobulin (IVIG)
    • Subcutaneous Immunoglobulin (SCIG)
  • Coagulation Factors
    • Factor IX
    • Factor VIII
    • Prothrombin Complex Concentrates
    • Fibrinogen Concentrates
    • Others
  • Protease Inhibitors
  • Others

By Application

  • Immunology & Neurology
  • Haematology
  • Critical Care
  • Pulmonology
  • Others

By End-user

  • Hospitals & Clinics
  • Clinical Research Laboratories
  • Others
  • 2019-2030
  • 2022
  • 2019-2021
  • 70
Download Free Sample

    man icon
    Mail icon
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann